IRS posttranslational modifications in regulating insulin signaling
Jinghua Peng1,2, Ling He3
1Division of Metabolism and EndocrinologyDepartments of Pediatrics and Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract:
Insulin resistance is the hallmark of type 2 diabetes; however, the mechanism underlying the development of insulin resistance is still not completely understood. Previous reports showed that posttranslational modifications of IRS play a critical role in insulin signaling, especially the phosphorylation of IRS by distinct kinases. While it is known that increasing Sirtuin1 deacetylase activity improves insulin sensitivity in the liver, the identity of its counterpart, an acetyl-transferase, remains unknown. Our recent study shows that elevated endotoxin (LPS) levels in the liver of obese mice lead to the induction of the acetyl-transferase P300 through the IRE1-XBP1s pathway. Subsequently, induced P300 impairs insulin signaling by acetylating IRS1 and IRS2 in the insulin signaling pathway. Therefore, the P300 acetyl-transferase activity appears to be a promising therapeutic target for the treatment of diabetes.
Insights
Elevated endotoxin in obese mice induces P300 acetyltransferase, impairing insulin signaling by modifying IRS1/2. Targeting P300 may treat type 2 diabetes.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Insulin resistance is central to type 2 diabetes, but its mechanisms are unclear.
- Posttranslational modifications of insulin receptor substrate (IRS) are crucial for insulin signaling.
- Sirtuin 1 enhances insulin sensitivity, but its opposing acetyltransferase remains unidentified.
Purpose of the Study:
- To identify the acetyltransferase involved in insulin resistance.
- To investigate the role of endotoxin (LPS) and the IRE1-XBP1s pathway in this process.
- To explore P300 as a potential therapeutic target for diabetes.
Main Methods:
- Utilized obese mouse models with elevated liver endotoxin (LPS) levels.
- Investigated the IRE1-XBP1s pathway activation.
- Assessed the acetylation of IRS1 and IRS2 by P300.
- Analyzed insulin signaling pathway function.
Main Results:
- Elevated LPS levels in obese mice induced P300 expression via the IRE1-XBP1s pathway.
- Induced P300 acetylated IRS1 and IRS2, impairing insulin signaling.
- P300 activity was directly linked to insulin resistance in this model.
Conclusions:
- The P300 acetyltransferase, induced by LPS through IRE1-XBP1s, contributes to insulin resistance.
- P300-mediated acetylation of IRS proteins is a key mechanism in diabetes development.
- Inhibiting P300 activity presents a potential therapeutic strategy for type 2 diabetes.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
08:34Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
Published on: July 15, 2025
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
The JAK-STAT Signaling Pathway
